CorMedix Inc Forecast, price target & analysts
CorMedix Inc Target price 2026 - Analyst rating & recommendation
CorMedix Inc Classifications & Recommendation
CorMedix Inc Price Target
| Target Price | $15.30 |
| Price | $7.85 |
| Potential |
94.90%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target CorMedix Inc 2027 .
The average CorMedix Inc target price is $15.30.
This is
94.90%
register free of charge
$19.95
154.14%
register free of charge
$13.13
67.26%
register free of charge
|
|
| A rating was issued by 11 analysts: 10 Analysts recommend CorMedix Inc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the CorMedix Inc stock has an average upside potential 2027 of
94.90%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 311.71 | 343.83 |
| 617.07% | 10.30% | |
| EBITDA Margin | 52.83% | 37.75% |
| 204.16% | 28.55% | |
| Net Margin | 52.31% | 11.82% |
| 226.83% | 77.40% |
7 Analysts have issued a sales forecast CorMedix Inc 2026 . The average CorMedix Inc sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an CorMedix Inc EBITDA forecast 2026. The average CorMedix Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 CorMedix Inc Analysts have issued a net profit forecast 2026. The average CorMedix Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 2.03 | 0.52 |
| 776.67% | 74.38% | |
| P/E | 15.00 | |
| EV/Sales | 1.46 |
7 Analysts have issued a CorMedix Inc forecast for earnings per share. The average CorMedix Inc EPS is
This results in the following potential growth metrics and future valuations:
Current CorMedix Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Oppenheimer |
Locked
➜
Locked
|
Locked | Sep 23 2026 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Aug 14 2026 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Jul 07 2026 |
| Citizens |
Locked
➜
Locked
|
Locked | Apr 28 2026 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Apr 28 2026 |
| Leerink Partners |
Locked
➜
Locked
|
Locked | Apr 28 2026 |
| D. Boral Capital |
Locked
➜
Locked
|
Locked | Apr 27 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Oppenheimer:
Locked
➜
Locked
|
Sep 23 2026 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Aug 14 2026 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Jul 07 2026 |
|
Locked
Citizens:
Locked
➜
Locked
|
Apr 28 2026 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Apr 28 2026 |
|
Locked
Leerink Partners:
Locked
➜
Locked
|
Apr 28 2026 |
|
Locked
D. Boral Capital:
Locked
➜
Locked
|
Apr 27 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
